Abu-Shady, H., Experiments with Khellin VII., UAR J. Pharm. Sci., 11:283-288 (1970). |
Abu-Shady, H., et al., Experiments with Khellin-VIII, J. Pharm. Belg., 33:397-399 (1978). |
Anrep, G. V. et al., Therapeutic Uses of Khellin, The Lancet, pp. 557-558, Apr. 26, 1947. |
Anrep, G. V. et al., The Coronary Vasodilator Action of Khellin, Amer. Heart J., 37:531-542 (1949). |
Apffel, C. A., Die Zytostatische Wirkung von Chinonen und Ihren Derivaten, Deut. Med. Wochschr., 80:414-416 (1955). |
Aubertin, E., La Khelline, agent de relachement de la musculature lisse., J. Med. Bordeaux, 127:821-823 (1950). |
Baytop, O. T., Khellin'in Yer Solucanlarina Tesiri Hakkinda, Folia Pharm. (Turkey), 1:48-49 (1949). |
Best, M. M. et al., Effects of Dioxyline Phosphate and Enteric-Coated Khellin on Coronary Artery Insufficiency, Amer. J. Med. Sci. 222:35-39 (1951). |
Chen, G. et al., The Central Nervous Depressive Effect of Khellin, Proc. Soc. Expetl. Biol. Med., 78:305-307 (1951). |
Columbo, G. et al., Sulla attivita di alcune sostanze del gruppo della Kellina sulla motilita ureterale--in vitro--, Arch. Sci. Med. 97:71-81 (1954). |
Day, C. E. et al., Utility of a Selected Line (SEA) of the Japanese Quail for the Discovery of New Anti-Atherosclerosis Drugs, Laboratory Animal Science, 27:817-821 (1977). |
Eaton, R. P., High Density Lipoprotein--Key to Anti-Atherogenesis, J. Chron. Dis., 31:131-135 (1978). |
Haust, M. D., Reaction Patterns of Intimal Mesenchyme to Injury, and Repair in Atherosclerosis, Adv. Exp. Med. Biol., 43:35-57 (1974). |
Huttrer, C. P. et al., The Chemistry and Physiological Action of Khellin and Related Products, Chem. Revs., 48:543-579 (1951). |
Jordan, H., Cardiovasculare Wirkungen Intravenoser Khellin-Injektionen, Arzneimittel-Forsch 8:141-143 (1958), 7:82-85 (1957). |
LaBarre, J. et al., Action protectrice de la khelline vis-a-vis de pulcere gastrique experimental provoque, chez le chien, par l'administration de cinchophene, Compt. Rend. Soc. Biol., 150:598-599 (1956). |
LaBarre, J. et al., A propos de l'action inhibitrice de la khelline dans l'ulcere gastrique experimental provoque par administration journaliere de phenylbutazone, Compt. Rend. Soc. Biol., 150:1806-1807 (1956). |
Lian, C. et al., Etude Experimentale et Clinique de la Khelline, Acta. Cardiol. (Brussels), 5:373-388 (1950). |
Montorsi, W. et al., Sur L'Activite de Certaines Substances du Groupe de la Khelline, Presse Med., 63:81 (1955). |
Musante, C. et al., Furil E. Isossazol-Furo-Cromoni e Derivati, Pharmaco, (Pavie) Ed Sci., 15:81-94 (1960). |
Mustafa, A. et al., Experiments with Furochromones, Synthesis of Ammiol and Khellol, J. Org., Chem., 26:886-890 (1961). |
Mustafa, A., Furopyrans and Furopyrones, John Wiley and Sons, Inc., NY (1967), pp. 102-159 (Chapter III: Furochromones). |
Osher, H. L., et al., Khellin in the Treatment of Angina Pectoris, New England J. Med., 244:315-321 (1951). |
Raymond-Hamet, M., Compt. Rend., 238:1624-1626 (1954). |
Samaan, K. et al., The Response of the Heart to Visammin and to Khellinin, J. Pharm. Pharmacol., 1:538-544 (1949). |
Samaan, K. et al., The Existence in Ammi Visnaga of a Cardiac Depressant Principle Visammin and a Cardiac Stimulant Glycoside Khellinin, J. Roy. Egypt Med. Assoc., 33:953-960 (1950). |
Schonberg, A. et al., Khellin and Allied Compounds, JACS 72:1611-1617 (1950). |
Schonberg et al., Furo-Chromones and -Coumarins, XIV, JACS 77:5439-5440 (1955). |
Schurr, P. E., High Volume Screening Procedure for Hypobetalipoproteinemia Activity in Rats, Adv. Exp. Med. Biol. 67: Atherosclerotic Drug Discovery, pp. 215-229, Plenum Press (1975). |
Silber, E. N., The Effect of Khellin on Cardio-Pulmonary Function in Chronic Pulmonary Disease, published in 1951. |
Swayne, V. R. et al., Spermicidal Action of Khellin, Amer. J. Pharm., 125:295-298 (1953). |